Healthcare News: 12/03/2014

Photo: Yann Ropars, Flickr



  • Cigna receives a buy recommendation:

    A number of analysts have recently weighed in on CI shares. Analysts at Bank of America raised their price target on shares of CIGNA from $114.00 to $120.00 in a research note on Tuesday, November 18th. They now have a “buy” rating on the stock. Separately, analysts at Zacks reiterated a “neutral” rating on shares of CIGNA in a research note on Monday, November 10th. They now have a $104.00 price target on the stock

  • HDL will be laying off staff while in a lawsuit with Cigna:

    Cigna sued HDL last month in federal court, claiming over HDL was involved in a scheme to collect “exorbitant reimbursement rates for thousands of claims,” reported Forbes. The federal investigation, reported by the Wall Street Journal, focuses on $20 kickbacks HDL offered doctors to order tests. HDL has denied the allegations.

  • Cigna working with CT Chamber of Commerce on Critical Choice:

    In a fall enrollment season survey, Cigna discovered that 75 percent of respondents believed that health care costs could ruin their prospects of a secure retirement; while 44 percent worried they won’t have the money to pay for their child’s college education. Cigna’s Critical Choice coverage provides a lump sum payment for covered conditions to help an individual pay medical bills when the unexpected occurs.



United Health

Tagged , , ,